Related Experiment Video
Updated: Apr 29, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Diagnostic Value and Prognostic Effect of miR-7-5p in Cirrhosis
Wenchao Li1, Yanbing Tian1, Lijing Jing1
1Hepatology Department of integrated Chinese and Western medicine, Xingtai People's Hospital, Xingtai, China.
Introduction:
The purpose of this study was to examine miR-7-5p levels in patients with liver cirrhosis and its correlation with liver function, as well as to evaluate its clinical value as a diagnostic and prognostic biomarker.
Methods:
miR-7-5p levels in 86 liver cirrhosis patients and 95 healthy volunteers were measured using qRT-PCR. Pearson correlation analysis was employed to calculate the relationship between miR-7-5p and liver function indicators (alanine aminotransferase [ALT], aspartate aminotransferase [AST], PT, INR, total bilirubin [TBil], and albumin). ROC curve was conducted to evaluate its diagnostic significance. Additionally, Cox regression analysis and the Kaplan-Meier method were utilized to evaluate the prognostic significance of miR-7-5p.
Results:
The findings revealed that miR-7-5p was upregulated in the serum liver cirrhosis patients. Its levels positively correlated with ALT (r = 0.319, p = 0.003), AST (r = 0.424, p < 0.001), PT (r = 0.357, p < 0.001), INR (r = 0.312, p = 0.003), TBil (r = 0.557, p < 0.001), but negatively correlated with albumin (r = -0.484, p < 0.001). ROC curve analysis indicated that the AUC for miR-7-5p was 0.862, demonstrating high diagnostic value. Furthermore, high miR-7-5p levels were linked to poorer survival rates and were confirmed as an independent prognostic factor for liver cirrhosis (95% CI 1.442-11.811, p = 0.008).
Conclusion:
miR-7-5p not only demonstrated potential value in the diagnosis of liver cirrhosis but also effectively predicted patient prognosis. As a biomarker, miR-7-5p may provide important evidence for early diagnosis and the formulation of individualized care strategies for patients, thereby promoting improvements in clinical nursing practice.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

